摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

sym-methoxy[N,N'-bis(salicylidene)-1,3-diaminopropanato]oxorhenium | 212496-48-5

分子结构分类

中文名称
——
中文别名
——
英文名称
sym-methoxy[N,N'-bis(salicylidene)-1,3-diaminopropanato]oxorhenium
英文别名
——
sym-methoxy[N,N'-bis(salicylidene)-1,3-diaminopropanato]oxorhenium化学式
CAS
212496-48-5
化学式
C18H19N2O4Re
mdl
——
分子量
513.567
InChiKey
XOBMBGCDYUBLGV-YBRXSBAKSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    None
  • 重原子数:
    None
  • 可旋转键数:
    None
  • 环数:
    None
  • sp3杂化的碳原子比例:
    None
  • 拓扑面积:
    None
  • 氢给体数:
    None
  • 氢受体数:
    None

反应信息

  • 作为反应物:
    描述:
    sym-methoxy[N,N'-bis(salicylidene)-1,3-diaminopropanato]oxorhenium4-甲氧基苯酚二氯甲烷 为溶剂, 以99%的产率得到sym-(p-methoxyphenoxy)[N,N'-bis(salicylidene)-1,3-diaminopropanato]oxorhenium
    参考文献:
    名称:
    Rhenium(V)−Salen Complexes:  Configurational Control and Ligand Exchange
    摘要:
    Reactions of ReO(PPh3)(2)Cl-3 with tetradentate bis(salicylideneamine) ligands, H(2)salpd (1) and H(2)salbd (2), in different alcohols gave the novel mixed-ligand rhenium complexes ReO(sal)OAlk (OAlk = variety of alkoxy ligands). Configurational studies show that the rhenium complexes ReO(salpd)OAlk (1a-f) display either a symmetrical or a nonsymmetrical configuration, depending on the size of the alcohol and its boiling point. The rhenium complexes ReO(salbd)OAlk (2a-d) are all nonsymmetrical due to the number of carbons that bridge the imine nitrogens. In the case of the symmetrical ReO(salpd)OMe (la) complex the methoxy ligand can be exchanged for a number of ligands of different types (OAlk, OPh, SAlk, OC(O)Alk). In the newly formed complexes the original configuration was retained except for the ReO(salpd)SAlk (1i,j) complexes which were isolated in the nonsymmetrical configuration. Starting from the nonsymmetrical ReO(salpd)OPr (2c) complex, ligand exchange led to a mixture of the symmetrical and nonsymmetrical complexes, with ratios depending on the reaction time. The crystal structures of ReO(salbd)OPr (2c), and ReO(salpd)OPhOMe (Ig) have been determined. ReO(salbd)OPr crystallizes in the triclinic space group P (1) over bar, Z = 2, with a 10.0344(16) Angstrom, b = 10.647(2) Angstrom, c = 11.481(2) Angstrom, alpha = 86.551(15)degrees, beta = 86.998(14)degrees, gamma = 80.112(15)degrees, V = 1205.1(4) Angstrom(3), and final R = 0.0460. Crystals of ReO(salpd)OPhOMe are orthorhombic, space group P2(1)2(1)2(1), Z = 4, With a 10.6222(15) Angstrom, b = 12.442(3) Angstrom, c = 16.354(3) Angstrom, V = 2161.4(7) Angstrom(3) and final R = 0.0371. Under the influence of traces of water a number of symmetrical complexes react to a "dimeric" structure, consisting of two ReO(salpd) moieties bridged by an oxygen atom with the bridging Re-O-Re angle symmetrically imposed at 180 degrees. [ReO(salpd)](2)O (3) crystallizes in the monoclinic, space group P2(1)/c, Z = 4, with a = 14.860(2) Angstrom, b = 12.545(2) Angstrom, 16.5111(17) Angstrom, beta = 95.030(10)degrees, V = 3066.1(7) Angstrom(3), and final R = 0.0439.
    DOI:
    10.1021/ic980125t
  • 作为产物:
    描述:
    甲醇 、 [ReOCl3(PPh3)2] 、 N,N'-二亚水杨基-1,3-二氨基丙烷 在 Et3N 作用下, 以 甲醇 为溶剂, 以36%的产率得到sym-methoxy[N,N'-bis(salicylidene)-1,3-diaminopropanato]oxorhenium
    参考文献:
    名称:
    Rhenium(V)−Salen Complexes:  Configurational Control and Ligand Exchange
    摘要:
    Reactions of ReO(PPh3)(2)Cl-3 with tetradentate bis(salicylideneamine) ligands, H(2)salpd (1) and H(2)salbd (2), in different alcohols gave the novel mixed-ligand rhenium complexes ReO(sal)OAlk (OAlk = variety of alkoxy ligands). Configurational studies show that the rhenium complexes ReO(salpd)OAlk (1a-f) display either a symmetrical or a nonsymmetrical configuration, depending on the size of the alcohol and its boiling point. The rhenium complexes ReO(salbd)OAlk (2a-d) are all nonsymmetrical due to the number of carbons that bridge the imine nitrogens. In the case of the symmetrical ReO(salpd)OMe (la) complex the methoxy ligand can be exchanged for a number of ligands of different types (OAlk, OPh, SAlk, OC(O)Alk). In the newly formed complexes the original configuration was retained except for the ReO(salpd)SAlk (1i,j) complexes which were isolated in the nonsymmetrical configuration. Starting from the nonsymmetrical ReO(salpd)OPr (2c) complex, ligand exchange led to a mixture of the symmetrical and nonsymmetrical complexes, with ratios depending on the reaction time. The crystal structures of ReO(salbd)OPr (2c), and ReO(salpd)OPhOMe (Ig) have been determined. ReO(salbd)OPr crystallizes in the triclinic space group P (1) over bar, Z = 2, with a 10.0344(16) Angstrom, b = 10.647(2) Angstrom, c = 11.481(2) Angstrom, alpha = 86.551(15)degrees, beta = 86.998(14)degrees, gamma = 80.112(15)degrees, V = 1205.1(4) Angstrom(3), and final R = 0.0460. Crystals of ReO(salpd)OPhOMe are orthorhombic, space group P2(1)2(1)2(1), Z = 4, With a 10.6222(15) Angstrom, b = 12.442(3) Angstrom, c = 16.354(3) Angstrom, V = 2161.4(7) Angstrom(3) and final R = 0.0371. Under the influence of traces of water a number of symmetrical complexes react to a "dimeric" structure, consisting of two ReO(salpd) moieties bridged by an oxygen atom with the bridging Re-O-Re angle symmetrically imposed at 180 degrees. [ReO(salpd)](2)O (3) crystallizes in the monoclinic, space group P2(1)/c, Z = 4, with a = 14.860(2) Angstrom, b = 12.545(2) Angstrom, 16.5111(17) Angstrom, beta = 95.030(10)degrees, V = 3066.1(7) Angstrom(3), and final R = 0.0439.
    DOI:
    10.1021/ic980125t
点击查看最新优质反应信息

同类化合物

()-2-(5-甲基-2-氧代苯并呋喃-3(2)-亚乙基)乙酸乙酯 (甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (反式)-4-壬烯醛 (双(2,2,2-三氯乙基)) (乙腈)二氯镍(II) (乙基N-(1H-吲唑-3-基羰基)ethanehydrazonoate) (βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (±)17,18-二HETE (±)-辛酰肉碱氯化物 (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (s)-2,3-二羟基丙酸甲酯 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 ([2-(萘-2-基)-4-氧代-4H-色烯-8-基]乙酸) ([1-(甲氧基甲基)-1H-1,2,4-三唑-5-基](苯基)甲酮) (Z)-5-辛烯甲酯 (Z)-4-辛烯醛 (Z)-4-辛烯酸 (Z)-3-[[[2,4-二甲基-3-(乙氧羰基)吡咯-5-基]亚甲基]吲哚-2--2- (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-(-)-5'-苄氧基苯基卡维地洛 (S)-(-)-2-(α-(叔丁基)甲胺)-1H-苯并咪唑 (S)-(-)-2-(α-甲基甲胺)-1H-苯并咪唑 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-(+)-5,5'',6,6'',7,7'',8,8''-八氢-3,3''-二叔丁基-1,1''-二-2-萘酚,双钾盐 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-盐酸沙丁胺醇 (S)-溴烯醇内酯 (S)-氨氯地平-d4 (S)-氨基甲酸酯β-D-O-葡糖醛酸 (S)-8-氟苯并二氢吡喃-4-胺 (S)-7,7-双[(4S)-(苯基)恶唑-2-基)]-2,2,3,3-四氢-1,1-螺双茚满 (S)-4-(叔丁基)-2-(喹啉-2-基)-4,5-二氢噁唑 (S)-4-氯-1,2-环氧丁烷 (S)-3-(((2,2-二氟-1-羟基-7-(甲基磺酰基)-2,3-二氢-1H-茚满-4-基)氧基)-5-氟苄腈 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-3-(2-(二氟甲基)吡啶-4-基)-7-氟-3-(3-(嘧啶-5-基)苯基)-3H-异吲哚-1-胺 (S)-2-(环丁基氨基)-N-(3-(3,4-二氢异喹啉-2(1H)-基)-2-羟丙基)异烟酰胺 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-2-N-Fmoc-氨基甲基吡咯烷盐酸盐 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (SP-4-1)-二氯双(喹啉)-钯 (SP-4-1)-二氯双(1-苯基-1H-咪唑-κN3)-钯